Bibliographic citations
Villoslada, J., (2020). Sobrevida en cáncer de cérvix según tipo histológico: adenocarcinoma, carcinoma de células escamosas [Tesis, Universidad Privada Antenor Orrego - UPAO]. https://hdl.handle.net/20.500.12759/6391
Villoslada, J., Sobrevida en cáncer de cérvix según tipo histológico: adenocarcinoma, carcinoma de células escamosas [Tesis]. : Universidad Privada Antenor Orrego - UPAO; 2020. https://hdl.handle.net/20.500.12759/6391
@misc{renati/371259,
title = "Sobrevida en cáncer de cérvix según tipo histológico: adenocarcinoma, carcinoma de células escamosas",
author = "Villoslada Terrones, Jorge Enrique",
publisher = "Universidad Privada Antenor Orrego - UPAO",
year = "2020"
}
OBJECTIVE. To compare global survival and disease-free survival in patients with cervical cancer according to histological type: adenocarcinoma compared to 5-year squamous cell carcinoma MATERIAL AND METHODS. A retrospective, analytical longitudinal cohort study was conducted with data from patients with cervical cancer, of the medical records at the National Institute of Neoplastic Diseases from 2010 to 2014 with follow-up until January 2020. Survival analysis was performed with Kaplan-Meier to compare both types histological and cox regression to assess prognostic factors. Results: 558 patients with cervical cancer were enrolled, of which 75.27% correspond to the CCE and 24.73% to the AC. Disease free survival was not statistically significant when comparing both histological types CCE vs AC (65% vs. 66%, p = 0.819). The overall survival was statistically significant between the CCE and AC (65% vs. 78%, p = 0.002). The prognostic factors in the multivariate analysis for overall survival were histological type p = 0.04, Clinical stage p <0.01, response to treatment p <0.001. Conclusion: The histological type adenocarcinoma has a better overall survival compared to squamous cell carcinoma (HR = 0.64), there is no difference in terms of disease-free survival in both histological types.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.